Isotrak knows that the demands placed on delivery fleets are constantly evolving and customers require greater insight into fleet operations so it uses business intelligence data to provide retailers and manufacturers with a total vision of their transportation ecosystem. Expanding the capabilities of its real-time ATMSi fleet management system, Isotrak provides integrated supply chain solutions that access real-time data with robust alerting and reporting capabilities.With 25% of the world’s top food retailers using Isotrak products, Isotrak required quicker access to analytics for its IoT/M2M deployments – delivered with reliable reporting methods and at a low total cost of ownership.

Mevia provides intelligent solutions to improve the quality of medical treatments. Mevia develops solutions that enable people to take the right medication at the right time. This helps improve adherence, which is one of the greatest obstacles to successful medical treatments. According to statistics from the IMS Health Institute poor adherence costs over $500bn globally in avoidable healthcare costs and the World Health Organisation said that, “improving adherence would have a greater impact on health than any potential discovery in medicine.” Mevia has created technology, which can be adapted to work in blister packs, pill dispensers, and pill pouches, providing patient support and personal adherence feedback in real-time. Missed medication and adherence is a huge challenge globally for healthcare providers and pharmaceutical companies alike. Up to $289bn is spent on missed medication and adherence issues in the US, and the global pharmaceutical market’s revenue loss is estimated to be $564 billion due to medication non adherence. Being an innovative, yet growing company, Mevia needed to partner with an expert in IoT. However, this partner needed to offer competitive pricing, global coverage, and the agility to adapt their services as Mevia grows. Many providers had high fixed costs which would prove to be a deal breaker for Mevia.